TABLE 4.
Placebo | Supplemented | ||||||||
---|---|---|---|---|---|---|---|---|---|
Assessment | Subtest or variable | Age (mo) | Mean | SD | n | Mean | SD | n | Effect size1 (d) |
Willatts Task | Total score | 10 | 8.84 | 4.21 | 92 | 9.14 | 4.53 | 105 | 0.068 |
Delayed Response | Initial trials | 24 | 4.00 | 2.82 | 74 | 3.81 | 2.93 | 81 | 0.063 |
— | 30 | 3.98 | 3.20 | 73 | 4.91 | 3.52 | 81 | 0.278 | |
Reversal trials | 24 | 5.38 | 3.58 | 75 | 4.95 | 3.14 | 81 | 0.128 | |
— | 30 | 4.97 | 3.35 | 73 | 3.88 | 3.06 | 83 | 0.340 | |
Dimensional Change Card Sort | Preswitch total | 36 | 4.75 | 1.68 | 79 | 5.16 | 1.61 | 93 | 0.252 |
— | 42 | 5.82 | 0.89 | 76 | 5.62 | 1.08 | 91 | 0.202 | |
— | 48 | 5.86 | 0.60 | 78 | 5.92 | 0.48 | 89 | 0.116 | |
— | 60 | 5.87 | 0.78 | 74 | 6.00 | 0.00 | 84 | 0.369 | |
Postswitch total | 36 | 2.13 | 2.11 | 79 | 1.97 | 2.43 | 93 | 0.070 | |
— | 42 | 1.93 | 2.57 | 76 | 2.01 | 2.59 | 91 | 0.030 | |
— | 48 | 3.17 | 2.81 | 78 | 3.27 | 2.88 | 89 | 0.036 | |
— | 60 | 4.58 | 2.35 | 74 | 4.32 | 2.56 | 84 | 0.106 | |
Percent passing | 36 | 0.39 | 0.49 | 79 | 0.52 | 0.50 | 93 | 0.250 | |
— | 42 | 0.61 | 0.49 | 76 | 0.57 | 0.50 | 91 | 0.083 | |
— | 48 | 0.74 | 0.44 | 78 | 0.75 | 0.43 | 89 | 0.021 | |
— | 60 | 0.86 | 0.35 | 74 | 0.86 | 0.35 | 84 | 0.003 | |
Stroop tasks | Total score | 36 | 7.46 | 5.32 | 56 | 8.32 | 4.73 | 67 | 0.171 |
— | 42 | 8.05 | 4.69 | 67 | 8.77 | 4.56 | 81 | 0.157 | |
— | 48 | 10.22 | 5.03 | 73 | 10.66 | 5.04 | 82 | 0.086 | |
— | 60 | 12.45 | 4.63 | 74 | 13.13 | 4.07 | 83 | 0.156 | |
Tower of Hanoi | Max steps | 60 | 5.28 | 1.45 | 71 | 5.11 | 1.54 | 79 | 0.113 |
— | 72 | 6.15 | 1.18 | 66 | 6.17 | 0.87 | 79 | 0.013 | |
Efficiency | 60 | 16.94 | 8.58 | 71 | 16.29 | 8.74 | 79 | 0.075 | |
— | 72 | 24.56 | 8.34 | 66 | 24.15 | 6.79 | 79 | 0.055 |
None of the effects reported here for placebo compared with supplemented attained statistical significance, except the main effect for Delayed Response (P < 0.05).